Literature DB >> 31323356

Interstitial lung disease associated with anti-PM-Scl antibody: A single center experience.

Kamonpun Ussavarungsi1, Kenneth Nugent2, Alicia K Gerke3, Matthew D Krasowski4, Rebecca S Tuetken5, Petar S Lenert5.   

Abstract

Entities:  

Keywords:  Anti-PM-Scl antibody; Interstitial lung disease; Sclerodermatomyositis; Scleromyositis

Mesh：

Substances：

Year:  2019        PMID： 31323356     DOI： 10.1016/j.autrev.2019.102355

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN： 1568-9972            Impact factor:   9.754


× No keyword cloud information.
  2 in total

1.  IL-10/IL-10 receptor 1 pathway promotes the viability and collagen synthesis of pulmonary fibroblasts originated from interstitial pneumonia tissues.

Authors:  Hong Ye; Jiongwei Pan; Xiaoping Cai; Zhangyong Yin; Lu Li; Enhui Gong; Cunlai Xu; Hao Zheng; Zhuo Cao; Enguo Chen; Junfeng Qian
Journal:  Exp Ther Med       Date:  2022-06-15       Impact factor: 2.751

2.  Interstitial Lung Disease Is a Major Characteristic of Patients Who Test Positive for Anti-PM/Scl Antibody.

Authors:  Yongpeng Ge; Xiaoming Shu; Linrong He; Chunjia Li; Xin Lu; Guochun Wang
Journal:  Front Med (Lausanne)       Date:  2022-01-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.